At a glance
Summary
UnitedHealth Group closed at 408.5 USD for the week ended 12 June 2026, up 2.3% on the week and 48.2% over 12 weeks. The stock remains 24.7% above its Trend Line and 5.6% below Fair Value, giving the setup a constructive but not fully confirmed profile. Sector context is mixed: UNH ranks well within US Healthcare on three-month performance, but it lagged a very strong Healthcare Plans industry where weekly breadth and relative strength are much broader.
- UNH gained 2.3% last week to 408.5 USD, leaving it 1.8% below its 416.0 USD 52-week high and in the top 96.0% of its one-year range.
- The Trend Signal is active with a four-week streak, while price sits 24.7% above the 327.6 USD Trend Line.
- Momentum remains strong across timeframes, led by a 48.2% 12-week return and a 34.0% 52-week return.
- Volume did not confirm the move, with 34.3M shares traded versus a 39.7M 13-week average and 50.8M 52-week average.
- Healthcare Plans breadth is much stronger than the broader Healthcare sector, but UNH’s 2.3% week trailed the industry’s 8.8% average return.
Company analysis
The move in context
Weekly tape: strong recovery, lighter participation
UnitedHealth’s latest week kept the recovery intact. The stock closed at 408.5 USD, up 2.3% for the week, after a 5.0% gain in the prior week and a sharp advance from the April base. The 12-week return of 48.2% is the clearest evidence in the tape, with the 26-week and 52-week returns also positive at 20.4% and 34.0% respectively.
The move is now close to a key pressure point. UNH is only 1.8% below its 416.0 USD 52-week high and stands 24.7% above the 327.6 USD Trend Line. That distance supports the current regime, but it also raises the bar for fresh confirmation. Volume was 34.3M shares, equal to 0.9x the 13-week average and 0.7x the 52-week average, so the latest advance was orderly rather than emphatic.
Signal state: constructive, but Market Dynamics has cooled
The Sharemaestro setup remains a balanced read rather than a clean acceleration signal. The Trend Signal is active and has held for four weeks, with 16 active weeks over the past year, equal to 30.8% trend breadth. Market Dynamics remains positive at 1.03, but its four-week change is down 16.2% and the signal list shows no fresh buy indication.
Relative Strength is firmer, rising to 15.59 with a four-week change of 27.1%. That improvement argues the rebound has broadened beyond a simple oversold bounce. Still, the expectation reading is Undecided at 54.48%, which fits the mixed evidence: price and trend are constructive, but participation and the absence of fresh Market Dynamics confirmation keep the signal quality short of decisive.
Sector and industry context: UNH beats Healthcare, trails managed-care momentum
Against the broader US Healthcare sector, UNH’s tape is respectable. The sector averaged a 0.8% weekly return, 3.5% over four weeks and 7.9% over 12 weeks, while UNH delivered 2.3%, 3.7% and 48.2% across the same periods. Its 12-week rank of seventh among 100 Healthcare names underlines the strength of the rebound.
The industry comparison is less flattering. US Healthcare Plans posted an average weekly return of 8.8%, a four-week gain of 14.6% and a 12-week gain of 66.9%. Breadth is also much stronger in the industry, with 81.8% trend breadth and 90.9% positive Market Dynamics breadth. Peers such as Humana, Oscar Health and Clover Health have posted much larger recent moves, leaving UNH as a high-quality recovery within the group but not the current momentum leader.
Fair Value, risk and what to watch next
UNH trades 5.6% below the 432.6 USD Fair Value reading, which is unusual for a stock sitting so close to its 52-week high. That gap suggests the market is still applying a discount despite the sharp recovery. The opportunity evidence is the active Trend Signal, positive Market Dynamics and the premium to the Trend Line; the risk evidence is lighter volume and a recent Market Dynamics cooling from earlier June levels.
Risk remains manageable but not low. Thirteen-week volatility is 4.6%, below the 52-week level of 6.1%, and the past year has seen 29 upside weeks against 23 downside weeks. Average up weeks have gained 4.5%, while average down weeks have lost 4.0%. The next test is whether UNH can challenge the 416.0 USD high with stronger participation, ideally a volume ratio above 1.5x, while holding the Trend Line as the key weekly regime marker.
Peer comparison
How the wider group is behaving
Breadth shows how much of the sector or industry is participating. A company move is more convincing when its peers are improving too.
US Healthcare
100 tracked companiesAbove Trend Line33.0%
Positive Relative Strength31.0%
US Healthcare Plans
11 tracked companiesAbove Trend Line81.8%
Positive Relative Strength81.8%
Balanced view
What supports the case, and what could weaken it
What is working
- Trend Signal is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
What needs caution
- Price is below Fair Value, so the market is still discounting the latest tape.
Research note
This article is for educational market research only and is not financial, investment, trading, tax, or legal advice. Sharemaestro does not make buy, sell, or hold recommendations.
Source and attribution
Source: Sharemaestro. Canonical article: https://sharemaestro.com/news/unh-48-percent-quarter-near-high-healthcare-plans-volume/.
Follow new Sharemaestro research through the RSS feed or JSON feed.